ENGNW
enGene Therapeutics Inc.Warrants of enGene Therapeutics Inc. · ENGN stock page →
—
Market cap
$15.4M
Nano cap
1 year
−80.2%
from $7.96 · Oct 27
30 days
−20.1%
from $1.97
52-week range
$1.44–12.17
−87% from high · low May 12
Avg volume 20D
826.3K
shares / day
Short interest
🔒 Subscribers only
New fund stakes
0
Q1 2026 13F · 0 exits
Price
Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.
No data for this timeframe.
- X Aug 31 Short interest falls 90.4% to 4.7K
- X Sep 15 Short interest falls 63.6% to 1.7K
Signal stack
Where each data set points today.
- InstitutionsMIXED
Q1 2026: 1 added (0 new), 0 trimmed or exited.
- TrendDOWNTREND
13% below its 50-day average.
Who's buying
13F· Q1 20260
new positions
0
exits
| Fund | Move | Value |
|---|---|---|
| LMR Partners LLP | DOUBLED | $811.3K |
| Caption Management, LLC | DOUBLED | $420.0K |
| WOLVERINE ASSET MANAGEMENT LLC | TRIM | $48.0K |
| UBS Group AG | TRIM | $4.8K |
| UBS Group AG | DOUBLED | $13.2K |
| BANK OF AMERICA CORP /DE/ | ADD | $180.00 |
Quarterly 13F filings are due 45 days after each quarter ends.
Earnings setup
Estimates| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | — | — | — | $0.00 |
| Next Q | — | — | — | $0.00 |
| Current FY | — | — | — | $0.00 |
| Next FY | — | — | — | $5.6M |
Short side
FINRA· Oct 15, 2026🔒 Subscribers only
shares short
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Mar 31, 2026 Inst.
LMR Partners LLP — DOUBLED
320,687 shares ($811.3K)
Dec 31, 2025 Inst.
Caption Management, LLC — DOUBLED
141,904 shares ($420.0K)